Francesca Romana Mauro, Dr

Department of Translational and Precision Medicine, Hematology unit, 'Sapienza' University, Italy

NA

Poster(s):

• 1007 - XPO1 mutations identify early stage CLL characterized by shorter time to first treatment and enhanced BCR signaling

• 2022 - Prolonged treatment with ibrutinib modulates phenotypic and functional features of immune cell compartments in chronic lymphocytic leukemia